...
首页> 外文期刊>Journal of peptide science: An official publication of the European Peptide Society >Conformational and biological properties of Bauhinia bauhinioides kallikrein inhibitor fragments with bradykinin-like activities
【24h】

Conformational and biological properties of Bauhinia bauhinioides kallikrein inhibitor fragments with bradykinin-like activities

机译:具有缓激肽样活性的紫荆花紫荆素激肽释放酶抑制剂片段的构象和生物学特性

获取原文
获取原文并翻译 | 示例
           

摘要

Proteinase inhibitors extracted form medicinal plants are an interesting source of new drugs. Modifications in the structure of some of this kind of macromolecules could also lead to compounds of interesting biological properties. In this work, we synthesized and tested one fragment containing the reactive site of the Bauhinia bauhinioides kallikrein inhibitor (BbKI), denoted BbKI(51-62), and a related analog (P-2) in which a proline residue was inserted in order to mimic the N-terminal region of the bradykinin molecule. The related retro-inverso counterparts Ri-BbKI(51-62) and Ri-P-2 were also included. The ability of these peptides to induce contraction of stomach fundus isolated from mouse was evaluated as well as their capability to induce calcium release from a cell culture of smooth muscle from guinea pig ileum. The conformational properties of the peptides were evaluated by circular dichroism and their resistance to enzymatic degradation by exposure to human blood plasma. Our results show that neither the parent BbKI(51-62) nor its Ri-BbKI(51-62) analog exhibit bradykinin-like activity, although the retro-inverso isomer was resistant to blood plasma degradation. On the other hand, the peptides P-2 and Ri-P-2 presented contractile activities on gastric smooth muscle from stomach fundus possibly by acting via B-2 receptor. Both compounds also induce calcium release from guinea pig ileum muscle cells in a manner similar to bradykinin. Moreover, both compounds also inhibited porcine pancreatic kallikrein. However, conformational analysis did not reveal any direct correlation between structure and biological effects. Copyright (c) 2015 European Peptide Society and John Wiley & Sons, Ltd.
机译:从药用植物中提取的蛋白酶抑制剂是新药的有趣来源。某些这类大分子的结构修饰也可能导致具有有趣生物特性的化合物。在这项工作中,我们合成并测试了一个片段,该片段包含紫荆花紫荆素激肽释放酶抑制剂(BbKI)的反应位点(表示为BbKI(51-62))和相关类似物(P-2),其中脯氨酸残基按顺序插入模仿缓激肽分子的N末端区域。相关的逆反对应物Ri-BbKI(51-62)和Ri-P-2也包括在内。评价了这些肽诱导从小鼠分离的胃底收缩的能力以及它们诱导豚鼠回肠平滑肌细胞培养物中钙释放的能力。通过圆二色性评价肽的构象性质,并通过暴露于人血浆来评价其对酶促降解的抗性。我们的结果表明,尽管逆向异构体对血浆降解具有抵抗力,但亲本BbKI(51-62)或其Ri-BbKI(51-62)类似物均未显示缓激肽样活性。另一方面,肽P-2和Ri-P-2可能通过B-2受体起作用,从胃底对胃平滑肌呈现收缩活性。两种化合物还以类似于缓激肽的方式诱导豚鼠回肠肌细胞释放钙。此外,这两种化合物还抑制猪胰激肽释放酶。但是,构象分析并未揭示结构和生物学效应之间的任何直接关系。版权所有(c)2015欧洲多肽协会和John Wiley&Sons,Ltd.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号